PureHealth has accomplished the acquisition of a 60 per cent stake in Hellenic Healthcare Group (HHG), Greece and Cyprus’s main personal healthcare supplier, for €800m ($868m).
The transaction implies a 100 per cent fairness valuation of €1.3bn ($1.4bn) for HHG and represents a key milestone in PureHealth’s technique to construct a globally linked, innovation-driven healthcare platform from its base in Abu Dhabi.
By means of the mixing of HHG’s 11 hospitals and 23 diagnostic centres, PureHealth will increase entry to healthcare providers for greater than 1.4 million sufferers yearly.
PureHealth growth
With greater than 6,700 healthcare professionals, HHG now turns into an integral a part of PureHealth’s worldwide ecosystem, reinforcing Abu Dhabi’s place as a worldwide hub for healthcare excellence and funding.
A signing ceremony was held in Greece, attended by HE Kyriakos Pierrakakis, Minister of Nationwide Financial system and Finance of the Hellenic Republic; HE Adonis Georgiadis, Minister of Well being of the Hellenic Republic; and HE Dr Ali Obaid Ali Alyabhouni Al Dhaheri, Ambassador of the United Arab Emirates to the Hellenic Republic, together with senior leaders from PureHealth, CVC Capital Companions, and HHG.
Kamal Al Maazmi, Chairman of PureHealth, stated: “Finalising this transaction is a vital milestone in our journey to create a globally linked healthcare platform. PureHealth has demonstrated the flexibility to supply, execute and safe regulatory approvals in mature markets, reflecting its strengths and worldwide credibility.”
“With HHG, we at the moment are increasing into new geographies, facilitating data alternate, and fostering innovation that may improve affected person outcomes throughout our community. Importantly, this acquisition has been accomplished utilizing PureHealth’s sturdy stability sheet, and we count on to recognise the monetary upside from 1 October 2025.”
Shaista Asif, Group CEO of PureHealth, stated: “Welcoming HHG into the Group accelerates our imaginative and prescient of delivering superior, patient-centred healthcare throughout borders. This transaction strengthens medical experience, broadens entry to high quality care, and diversifies revenues throughout mature geographies and currencies.”
“It underscores our long-term dedication to worth creation for sufferers, communities, and our shareholders. Central to PureHealth’s ambition is the facility of AI and our increasing digital footprint, which allow us to rework healthcare supply on a worldwide scale.”
Strategic acquisitions construct diversified international community
The HHG deal follows PureHealth’s current worldwide growth, together with the $1.2bn (AED 4.4bn) buy of Circle Well being Group, the UK’s largest unbiased hospital operator, in 2024, and a $500m (AED1.8bn) funding in Ardent Well being Providers in 2022, culminating in Ardent’s profitable IPO on the New York Inventory Trade in 2024.
Every transaction displays PureHealth’s disciplined strategy to buying high-quality belongings and constructing a diversified international portfolio throughout a number of geographies and currencies.
Alex Fotakidis, Companion and Head of Greece at CVC Capital Companions, stated: “We’re proud to have supported HHG’s progress into Greece and Cyprus’s main personal healthcare supplier.
“This partnership with PureHealth is a powerful endorsement of HHG’s high quality, scale, and future potential.”
“By combining PureHealth’s worldwide experience with HHG’s established presence in Southern Europe, we’re assured this transaction will ship lasting worth for sufferers and staff, and speed up the expansion of HHG.”
Dimitris Spyridis, Chief Govt Officer of HHG, stated: “Becoming a member of forces with PureHealth marks an necessary milestone for HHG. Collectively, we’ll speed up innovation, improve affected person care, and strengthen our position because the main healthcare supplier in Greece and Cyprus.”
“PureHealth has a big emphasis on know-how, AI and healthcare of the long run. Subsequently we will probably be trying to combine finest practices not solely in scientific practices, but additionally throughout the know-how ecosystem.”
Following completion of the transaction, CVC Capital Companions and HHG administration retain a 40 per cent stake in HHG, guaranteeing continuity and supporting future progress.
